FGF23与Klotho参与气道炎症机制
研究探讨FGF23和Klotho在COPD气道炎症中的作用,利用患者血浆、支气管活检、原代气道上皮细胞及小鼠COPD模型,发现COPD患者血浆FGF23升高,香烟烟雾和FGF23通过非Klotho依赖的FGFR4激活PLCγ/NFAT信号促进IL-1β释放,Klotho敲除小鼠出现COPD样气道炎症,而上调Klotho可减轻炎症。
要点
- COPD患者血浆FGF23水平显著升高。
- 香烟烟雾下调Klotho并激活FGFR4,经PLCγ/NFAT通路促IL-1β释放。
- 抑制FGF23或FGFR4可能成为COPD抗炎新策略。
核心结论
- 香烟烟雾通过下调Klotho和激活气道上皮FGFR4诱导COPD气道炎症。
- 抑制FGF23或FGFR4可能成为COPD新型抗炎策略。
研究设计与样本
- 研究使用COPD患者和对照者的血浆及经支气管活检、COPD患者原代人气道上皮细胞以及小鼠COPD模型。
- 体外实验将气道上皮细胞暴露于香烟烟雾和FGF23,并分析信号通路。
- 使用Klotho敲除小鼠和Klotho过表达模型评估气道炎症。
主要发现
- COPD患者血浆FGF23水平显著升高。
- 气道上皮细胞暴露于香烟烟雾和FGF23后,通过非Klotho依赖的FGFR4激活PLCγ/NFAT信号,导致IL-1β释放显著增加。
- Klotho敲除小鼠发生COPD,表现为气道炎症和肺内FGFR4表达升高。
- Klotho过表达可减轻气道炎症。
临床怎么用
- FGF23和FGFR4可能作为COPD气道炎症的生物标志物或治疗靶点。
- 未来可探索抑制FGF23或FGFR4的抗炎治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Circulating levels of fibroblast growth factor (FGF)23 are associated with systemic inflammation and increased mortality in chronic kidney disease. α-Klotho, a co-receptor for FGF23, is downregulated in chronic obstructive pulmonary disease (COPD). However, whether FGF23 and Klotho-mediated FGF receptor (FGFR) activation delineates a pathophysiological mechanism in COPD remains unclear. We hypothesised that FGF23 can potentiate airway inflammation via Klotho-independent FGFR4 activation.FGF23 and its effect were studied using plasma and transbronchial biopsies from COPD and control patients, and primary human bronchial epithelial cells isolated from COPD patients as well as a murine COPD model.Plasma FGF23 levels were significantly elevated in COPD patients. Exposure of airway epithelial cells to cigarette smoke and FGF23 led to a significant increase in interleukin-1β release via Klotho-independent FGFR4-mediated activation of phospholipase Cγ/nuclear factor of activated T-cells signalling. In addition, Klotho knockout mice developed COPD and showed airway inflammation and elevated FGFR4 expression in their lungs, whereas overexpression of Klotho led to an attenuation of airway inflammation.Cigarette smoke induces airway inflammation by downregulation of Klotho and activation of FGFR4 in the airway epithelium in COPD. Inhibition of FGF23 or FGFR4 might serve as a novel anti-inflammatory strategy in COPD.
引用
- Krick S, Grabner A, Baumlin N, et al. Fibroblast growth factor 23 and Klotho contribute to airway inflammation. Eur Respir J. 2018. PMID: 29748308. doi:10.1183/13993003.00236-2018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。